302 related articles for article (PubMed ID: 25644500)
1. The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.
Ramot Y; Mastrofrancesco A; Camera E; Desreumaux P; Paus R; Picardo M
Exp Dermatol; 2015 Apr; 24(4):245-51. PubMed ID: 25644500
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
Gupta M; Mahajan VK; Mehta KS; Chauhan PS; Rawat R
Arch Dermatol Res; 2015 Nov; 307(9):767-80. PubMed ID: 25986745
[TBL] [Abstract][Full Text] [Related]
4. PPAR-γ signalling as a key mediator of human hair follicle physiology and pathology.
Ramot Y; Bertolini M; Boboljova M; Uchida Y; Paus R
Exp Dermatol; 2020 Mar; 29(3):312-321. PubMed ID: 31769892
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.
Michalik L; Wahli W
Biochim Biophys Acta; 2007 Aug; 1771(8):991-8. PubMed ID: 17400022
[TBL] [Abstract][Full Text] [Related]
6. Abietic acid inhibits UVB-induced MMP-1 expression in human dermal fibroblast cells through PPARα/γ dual activation.
Jeon Y; Jung Y; Youm JK; Kang KS; Kim YK; Kim SN
Exp Dermatol; 2015 Feb; 24(2):140-5. PubMed ID: 25496486
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
9. [PPARgamma targeted genome-based drug discovery; present and future direction].
Miyachi H
Nihon Rinsho; 2010 Feb; 68(2):243-8. PubMed ID: 20158091
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors in cutaneous biology.
Kuenzli S; Saurat JH
Br J Dermatol; 2003 Aug; 149(2):229-36. PubMed ID: 12932225
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma and lung cancer biology: implications for therapy.
Roman J
J Investig Med; 2008 Feb; 56(2):528-33. PubMed ID: 18317436
[TBL] [Abstract][Full Text] [Related]
12. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
13. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia.
Karnik P; Tekeste Z; McCormick TS; Gilliam AC; Price VH; Cooper KD; Mirmirani P
J Invest Dermatol; 2009 May; 129(5):1243-57. PubMed ID: 19052558
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
Bishop-Bailey D; Bystrom J
Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
[TBL] [Abstract][Full Text] [Related]
15. New Insights into the Role of PPARγ in Skin Physiopathology.
Briganti S; Mosca S; Di Nardo A; Flori E; Ottaviani M
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927131
[TBL] [Abstract][Full Text] [Related]
16. Scarring alopecia and the PPAR-gamma connection.
Harries MJ; Paus R
J Invest Dermatol; 2009 May; 129(5):1066-70. PubMed ID: 19369934
[TBL] [Abstract][Full Text] [Related]
17. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J
J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model.
Demerjian M; Man MQ; Choi EH; Brown BE; Crumrine D; Chang S; Mauro T; Elias PM; Feingold KR
Exp Dermatol; 2006 Mar; 15(3):154-60. PubMed ID: 16480422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
